Yukimasa Shiotsu

A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response

Keith W. Pratz, Jörge E. Cortes, Gail J. Roboz et al. · Blood · 2008 · 182 citations · Full text

Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress

Masaki Ri, Shinsuke Iida, Takayuki Nakashima et al. · Leukemia · 2010 · 180 citations

Hematological Malignancy, Mutated Psmb5, Unfolded Proteins +7

Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing

Masaki Ri, Etsu Tashiro, Daisuke Oikawa et al. · Blood Cancer Journal · 2012 · 180 citations · Full text

Potent Inhibitor, Molecular Regulation, Molecular Biology +20

Systemic Distribution of Steroid Sulfatase and Estrogen Sulfotransferase in Human Adult and Fetal Tissues

Yasuhiro Miki, Taisuke Nakata, Takashi Suzuki et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 169 citations · Full text

KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.

Shiro Soga, LM Neckers, T W Schulte et al. · PubMed · 1999 · 137 citations

Hsp90 Binding, Hsp90 Family Proteins, Selective Depletion +16